Fig. 12From: Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascadeReal-time quantitative PCR analysis of Bax expression in untreated HepG2cells, and HepG2 treated by Formula (D4), MTX and their combination ratiosBack to article page